Company Website: http://www.johnsonandweaver.com
SAN DIEGO -- (Business Wire)

Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Catamaran Corporation (NASDAQ: CTRX) breached their fiduciary duties in connection with the proposed sale of the Company to OptumRx. OptumRx is UnitedHealth Group’s free-standing pharmacy care services business.

Additional Information:

Catamaran provides pharmacy benefit management services and healthcare information technology solutions to the healthcare benefits management industry in North America.

On March 30, 2015, Catamaran announced it had signed a definitive merger agreement with OptumRx. Under the terms of the merger agreement, OptumRx will acquire all of Catamaran’s outstanding common stock for $61.50 per share in cash.

The investigation concerns whether Catamaran’s board failed to satisfy their duties to the Company’s shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for the Company’s shares of common stock. Nationally recognized Johnson & Weaver, which focuses its practice on shareholder rights, is investigating whether the proposed deal price represents adequate consideration, especially given Catamaran’s promise of future growth. Moreover, one Wall Street analyst has a $66.00 price target on the stock which is more than the $61.50 offer price.

If you are a shareholder of Catamaran and believe the proposed buyout price is too low or you’re interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If emailing, please include a phone number where you can be reached.

About Johnson & Weaver, LLP:

Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contacts:

Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com

Source: Johnson & Weaver, LLP